UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 373

Sortiert nach

Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study

Clinical infectious diseases, 2020-07, Vol.71 (15), p.889-890

2020

Link zum Volltext

Verfügbarkeit prüfen

Genomic characterization and phylogenetic analysis of SARS‐COV‐2 in Italy

Journal of medical virology, 2020-09, Vol.92 (9), p.1637-1640

2020

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

BMC infectious diseases, 2017-08, Vol.17 (1), p.551-551, Article 551

2017

Link zum Volltext

Verfügbarkeit prüfen

Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding

Journal of acquired immune deficiency syndromes (1999), 2021-11, Vol.88 (3), p.234

2021

Link zum Volltext

Verfügbarkeit prüfen

Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study

PloS one, 2017-10, Vol.12 (10), p.e0186638-e0186638

2017

Link zum Volltext

Verfügbarkeit prüfen

Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study

International journal of infectious diseases, 2024-06, Vol.143, p.106956-106956, Article 106956

2024

Link zum Volltext

Verfügbarkeit prüfen

Does Syphilis Increase the Risk of HIV-RNA Elevation >200 Copies/mL in HIV-Positive Patients Under Effective Antiretroviral Treatment? Data From the ICONA Cohort

Journal of acquired immune deficiency syndromes (1999), 2021-10, Vol.88 (2), p.132

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors

Current medicinal chemistry, 2007-11, Vol.14 (26), p.2734

2007

Link zum Volltext

Verfügbarkeit prüfen

Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study

BMC infectious diseases, 2021-06, Vol.21 (1), p.595-9, Article 595

2021

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir plus lamivudine for hiv treatment: Does the historical genotype really matter?

EBioMedicine, 2020-06, Vol.56, p.102820-102820, Article 102820

2020

Link zum Volltext

Verfügbarkeit prüfen

Human-to-Cat SARS-CoV-2 Transmission: Case Report and Full-Genome Sequencing from an Infected Pet and Its Owner in Northern Italy

Pathogens (Basel), 2021-02, Vol.10 (2), p.252

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype

Viruses, 2023-03, Vol.15 (3), p.762

2023

Link zum Volltext

Verfügbarkeit prüfen

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data

BMC infectious diseases, 2017-09, Vol.17 (1), p.658-7, Article 658

2017

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcome

Journal of Anesthesia, Analgesia and Critical Care (Online), 2023-03, Vol.3 (1), p.6-6, Article 6

2023

Link zum Volltext

Verfügbarkeit prüfen

Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospective Study

Pathogens (Basel), 2023-10, Vol.12 (11), p.1298

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy

BMC infectious diseases, 2018-11, Vol.18 (1), p.556-556, Article 556

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 373

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(354)
Mit Volltextzugriff
(309)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study

Genomic characterization and phylogenetic analysis of SARS‐COV‐2 in Italy

Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding

Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study

Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients

Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study

Does Syphilis Increase the Risk of HIV-RNA Elevation >200 Copies/mL in HIV-Positive Patients Under Effective Antiretroviral Treatment? Data From the ICONA Cohort

Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors

A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)

Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study

Dolutegravir plus lamivudine for hiv treatment: Does the historical genotype really matter?

Human-to-Cat SARS-CoV-2 Transmission: Case Report and Full-Genome Sequencing from an Infected Pet and Its Owner in Northern Italy

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype

PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data

Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcome

Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors

Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospective Study

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting

Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19

Suchergebnisse filtern